Results 1 to 10 of about 5,600 (118)

Clinical Efficacy of CyberKnife Radiosurgery for Adult Brainstem Glioma: 10 Years Experience at Tianjin CyberKnife Center and Review of the Literature

Frontiers in Oncology, 2019
Background: Brainstem glioma is a rare brain tumor with poor prognosis and difficulty for surgical resection. We sought to retrospectively analyze and evaluate the clinical efficacy of CyberKnife for brainstem gliomas.Methods: From 2006 to 2015, a total ...
Jiaqi Zhang, Zhao Lujun
exaly   +3 more sources

Point Dosimetry in Patient-specific Quality Assurance of a Robotic Radiosurgery System Using a Scintillation Detector [PDF]

Journal of Medical Physics
Purpose: Patient-specific quality assurance (QA) for CyberKnife is typically performed using micro ionization chambers and film dosimetry. However, micro ionization chambers tend to underestimate dose measurements in small radiation fields.
Kohei Okawa, Yoshifumi Hirota
doaj   +2 more sources

Hypofractionated Stereotactic Radiotherapy with CyberKnife for Large Arteriovenous Malformations and Arteriovenous Malformations Located in Eloquent Areas

Neurologia Medico-Chirurgica, 2022
Literature has yet to establish an appropriate treatment strategy for large arteriovenous malformations (AVMs) and AVMs located in eloquent areas. In this study, the treatment outcomes of hypofractionated stereotactic radiotherapy (HSRT) with CyberKnife (
Ryoko NIWA, Shunsuke ICHI, Ryutaro NOMURA, Kengo SATO   +3 more
doaj   +1 more source

Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience

BMC Cancer, 2021
Background The optimal treatment for recurrent high-grade gliomas (rHGGs) remains uncertain. This study aimed to investigate the efficacy and safety of hypofractionated stereotactic radiosurgery (HSRS) as a first-line salvage treatment for in-field ...
Yun Guan, Ji Xiong, Mingyuan Pan, Wenyin Shi, Jing Li, Huaguang Zhu, Xiu Gong, Chao Li, Guanghai Mei, Xiaoxia Liu, Li Pan, Jiazhong Dai, Yang Wang, Enmin Wang, Xin Wang   +14 more
doaj   +1 more source

CyberKnife for Recurrent Malignant Gliomas: A Systematic Review and Meta-Analysis

Frontiers in Oncology, 2021
Background and ObjectivePossible treatment strategies for recurrent malignant gliomas include surgery, chemotherapy, radiotherapy, and combined treatments. Among different reirradiation modalities, the CyberKnife System has shown promising results.
Lucio De Maria, Lodovico Terzi di Bergamo, Alfredo Conti, Kazuhiko Hayashi, Valentina Pinzi, Taro Murai, Rachelle Lanciano, Sigita Burneikiene, Michela Buglione di Monale, Stefano Maria Magrini, Marco Maria Fontanella   +10 more
doaj   +1 more source

Dosimetric quality of HyperArc in boost radiotherapy for single glioblastoma: comparison with CyberKnife and manual VMAT

Radiation Oncology, 2023
Background Stereotactic radiotherapy (SRT) and hypo-fractionated radiotherapy are feasible treatment options for single glioblastoma multiforme when combined with conventional radiotherapy or delivered alone.
Mingyuan Pan, Wenqian Xu, Lei Sun, Chaozhuang Wang, Shengnan Dong, Yun Guan, Jun Yang, Enmin Wang   +7 more
doaj   +1 more source

Image-Guided Robotic Radiosurgery for the Treatment of Same Site Spinal Metastasis Recurrences

Frontiers in Oncology, 2021
BackgroundDue to recent medical advancements, patients suffering from metastatic spinal disease have a prolonged life expectancy than several decades ago, and some will eventually experience relapses.
Felix Ehret, Felix Ehret, Lucas Mose, Markus Kufeld, Christoph Fürweger, Christoph Fürweger, Paul Windisch, Paul Windisch, Alfred Haidenberger, Christian Schichor, Jörg-Christian Tonn, Alexander Muacevic   +11 more
doaj   +1 more source

Feasibility Study on Applying Radiophotoluminescent Glass Dosimeters for CyberKnife SRS Dose Verification. [PDF]

PLoS ONE, 2017
CyberKnife is one of multiple modalities for stereotactic radiosurgery (SRS). Due to the nature of CyberKnife and the characteristics of SRS, dose evaluation of the CyberKnife procedure is critical.
Shih-Ming Hsu, Chao-Hsiung Hung, Yi-Jen Liao, Hsiao-Mei Fu, Jo-Ting Tsai, Yung-Hui Huang, David Y C Huang   +6 more
doaj   +1 more source

A phase II open label, single arm study of hypofractionated stereotactic radiotherapy with chemoradiotherapy using intensity-modulated radiotherapy for newly diagnosed glioblastoma after surgery: the HSCK-010 trial protocol

BMC Cancer, 2022
Background The most frequently diagnosed primary brain tumor is glioblastoma (GBM). Nearly all patients experience tumor recurrence and up to 90% of which is local recurrence.
Yun Guan, Mingyuan Pan, Jun Yang, Qiuxia Lu, Liangfu Han, Ying Liu, Jing Li, Huaguang Zhu, Xiu Gong, Guanghai Mei, Xiaoxia Liu, Li Pan, Jiazhong Dai, Yang Wang, Enmin Wang, Xin Wang   +15 more
doaj   +1 more source

Stereotactic body radiation therapy for patients with heavily pretreated liver metastases and liver tumors

Frontiers in Oncology, 2012
We present our initial experience with CyberKnife stereotactic body radiation therapy (SBRT) in a heavily pretreated group of patients with liver metastases and primary liver tumors.
Rachelle eLanciano, Rachelle eLanciano, John eLamond, Jun eYang, Jing eFeng, Steven eArrigo, Michael eGood, Luther eBrady   +7 more
doaj   +1 more source